Novel Antibody Screening Technology

Technology Consulting: Novel Antibody Screening Technology Alacrita's antibody consultants were asked to help assess the market potential and develop a commercialization strategy for a novel antibody...
Learn More

Business Development and Partnering Support

Valuations For a biotech company engaged in licensing discussions with a number of major pharmaceutical companies, Alacrita developed rNPV valuations for each program. This 'theoretical' valuation...
Learn More

Intellectual Property Analysis & Strategy

Due diligence For a financial investor, Alacrita conducted an IP assessment on a late stage cell therapy  investment opportunity. The assessment revealed that the US and EPO patents relied on just...
Learn More

Antibodies

Target Assessment and intellectual property For a mid-cap pharmaceutical company seeking to establish a biologics pipeline through partnership with a mAb development boutique, Alacrita assessed the...
Learn More

Pharmaceutical & Biotech Due Diligence

Alacrita is a leading provider of due diligence to the pharmaceutical industry. Its core team of partners, each of whom has industry experience, are supported by a team of expert, life science...
Learn More
Content not found